Publication:
IGF-1 and IGFBP 3 in Growth Hormone Deficiency Role of Insulin Like Growth Factor-1 (IGF-1) and IGF Binding Protein 3 in the Diagnosis of Growth Hormone Deficiency: Changing Paradigm

creativeworkseries.issnISSN 1990-7974 eISSN 1990-7982
dc.contributor.authorKota, SK
dc.contributor.authorJammula, S
dc.contributor.authorGayatri, K
dc.contributor.authorKota, SK
dc.contributor.authorTripathy, PR
dc.contributor.authorModi, KD
dc.date.accessioned2026-05-27T07:01:32Z
dc.date.available2026-05-27T07:01:32Z
dc.date.issued2012
dc.descriptionSK Kota Department of Endocrinology, Medwin Hospital, Hyderabad, Andhra Pradesh S Jammula Department of Pharmaceutics, Roland Institute of Pharmaceutical Sciences, Berhampur, Orissa K Gayatri Department of Obstetrics and Gynaecology, Riyadh Care Hospital, Riyadh SK Kota Department of Anaesthesia, Central Security Hospital, Riyadh PR Tripathy Department of Anatomy, Kalinga Institute of Medical Sciences, Bhubaneswar, Orissa KD Modi Department of Endocrinology, Medwin Hospital, Hyderabad, Andhra Pradesh
dc.description.abstractAbstract: GH stimulation tests are widely used in the diagnosis of GH deficiency (GHD), although they are associated with a high false positive rate. Serum IGF-I levels are monitored during GH replacement treatment in subjects with GH deficiency (GHD) to guide GH dose adjustment and to minimize occurrence of GHrelated side-effects. The need for reliance on provocative testing is based on evidence that the evaluation of spontaneous growth hormone (GH) secretion over 24 hours and the measurement of IGF-I and IGFBP-3 levels do not distinguish between normal and GHD subjects. Regarding IGF-I, it has been demonstrated that very low levels in patients highly suspected for GHD (i.e., patients with childhood-onset, severe GHD, or with multiple hypopituitarism acquired in adulthood) may be considered definitive evidence for severe GHD obviating the need for provocative tests. However, normal IGF-I levels do not rule out severe GHD and therefore adults suspected for GHD and with normal IGF-I levels must undergo a provocative test of GH secretion. We hereby review the various literatures at disposal justifying the use of IGF-1 and IGBP3 for diagnosis of growth hormone deficiency. Data Source: We searched PUBMED and MEDLINE database for relevant articles including key words. References of each article were further reviewed for final synthesis of the manuscript.
dc.identifierhttps://doi.org/10.3126/jnps.v32i2.5342
dc.identifier.urihttps://hdl.handle.net/20.500.14572/6263
dc.language.isoen_US
dc.publisherNepal Paediatric Society (JNPS)
dc.subjectGrowth hormone deficiency
dc.subjectInsulin like Growth Factor 1
dc.subjectInsulin like growth factor binding protein 3
dc.titleIGF-1 and IGFBP 3 in Growth Hormone Deficiency Role of Insulin Like Growth Factor-1 (IGF-1) and IGF Binding Protein 3 in the Diagnosis of Growth Hormone Deficiency: Changing Paradigm
dc.typeArticle
dspace.entity.typePublication
local.article.typeReview Article
oaire.citation.endPage162
oaire.citation.startPage154
relation.isJournalIssueOfPublicationbee5f04f-02d7-4ebc-9b32-c948670b0393
relation.isJournalIssueOfPublication.latestForDiscoverybee5f04f-02d7-4ebc-9b32-c948670b0393
relation.isJournalOfPublication6f9be05c-05a9-4a3e-a5b5-a19a15ab042c

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
154-162.pdf
Size:
110.75 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections